Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.

Literature DB >> 33315080

The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.

Annette Rid¹, Marc Lipsitch², Franklin G Miller³.

Abstract

Entities: Species

Year: 2021 PMID： 33315080 DOI： 10.1001/jama.2020.25053

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Clinical Equipoise in COVID-19 Vaccine Candidate Trials.

Authors: Rafael Dal-Ré
Journal: J Clin Pharmacol Date: 2021-07-20 Impact factor: 2.860

2. The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.

Authors: Steven B Black; Barbara Law; Robert T Chen; Cornelia L Dekker; Miriam Sturkenboom; Wan-Ting Huang; Marc Gurwith; Greg Poland
Journal: Vaccine Date: 2021-03-06 Impact factor: 3.641

3. The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O).

Authors: Lisa Eckstein; Annette Rid; Dorcas Kamuya; Seema K Shah
Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079

4. The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World.

Authors: Ravi Jhaveri
Journal: Clin Ther Date: 2021-03-23 Impact factor: 3.393

5. How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available.

Authors: Nir Eyal; Marc Lipsitch
Journal: Clin Infect Dis Date: 2021-12-16 Impact factor: 9.079

Review 6. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.

Authors: Rafael Dal-Ré; Linda-Gail Bekker; Christian Gluud; Søren Holm; Vivekanand Jha; Gregory A Poland; Frits R Rosendaal; Brigitte Schwarzer-Daum; Esperança Sevene; Halidou Tinto; Teck Chuan Voo; Nadarajah Sreeharan
Journal: Lancet Infect Dis Date: 2021-05-18 Impact factor: 25.071

The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.

1. Clinical Equipoise in COVID-19 Vaccine Candidate Trials.

2. The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.

3. The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O).

4. The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World.

5. How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available.

Review 6. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.

7. How to continue COVID-19 vaccine clinical trials? The ethics of vaccine research in a time of pandemic.

8. Restrictions on the use of placebo in new COVID-19 vaccine trials.

9. Next steps for efficacy evaluation in clinical trials of COVID-19 vaccines.

10. Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants.